Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02375048
What this trial is testing

Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI

Who this might be right for
Cancer of Breast
Istituto Clinico Humanitas 179
Not applicableStudy completedNCT04286139
What this trial is testing

Self-management and HeAlth Promotion in Early-stage Dementia With E-learning for Carers

Who this might be right for
Dementia
Helse Stavanger HF 210
Not applicableUnknownNCT01157130
What this trial is testing

Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratory

Who this might be right for
Early Stage Breast Cancer (Stage 0-III)
Nevada Cancer Institute 100
Post-approval studies (Phase 4)WithdrawnNCT01302236
What this trial is testing

Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients

Who this might be right for
HypertensionChronic Kidney Disease.
Jichi Medical University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06733233
What this trial is testing

A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer

Who this might be right for
Breast Cancer, Estrogen Receptor-PositiveHER2 Low Breast Cancer
Guangzhou Women and Children's Medical Center 23
Testing effectiveness (Phase 2)Ended earlyNCT00090844
What this trial is testing

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Who this might be right for
Breast CancerHormone ChangesDrug Toxicity
University of South Florida 49
Not applicableStudy completedNCT03457792
What this trial is testing

Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 158
Not applicableUnknownNCT06455163
What this trial is testing

Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their Caregivers

Who this might be right for
Dementia, Mild
VU University of Amsterdam 102
Testing effectiveness (Phase 2)Study completedNCT00387699
What this trial is testing

Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group 79
Not applicableNot Yet RecruitingNCT06842030
What this trial is testing

Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing

Who this might be right for
Personalized MedicineOligometastatic DiseaseFeasibility
Good Samaritan Hospital Medical Center, New York 20
Not applicableStudy completedNCT01515800
What this trial is testing

S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 724
Testing effectiveness (Phase 2)Ended earlyNCT03547999
What this trial is testing

A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC

Who this might be right for
Metastatic Colorectal Cancer
Patrick Boland 17
Large-scale testing (Phase 3)Looking for participantsNCT07010263
What this trial is testing

AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Who this might be right for
Small Cell Lung Cancer
Akeso 560
Testing effectiveness (Phase 2)Study completedNCT03009682
What this trial is testing

Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations

Who this might be right for
Small Cell Lung Cancer
Samsung Medical Center 15
Large-scale testing (Phase 3)UnknownNCT04980859
What this trial is testing

Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation

Who this might be right for
Chronic Lymphocytic Leukemia
Nanfang Hospital, Southern Medical University 45
Testing effectiveness (Phase 2)Ended earlyNCT02906020
What this trial is testing

A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation

Who this might be right for
Parkinson's Disease
Genzyme, a Sanofi Company 273
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001762
What this trial is testing

TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer

Who this might be right for
Breast CancerEarly-stage Breast CancerHigh Risk Breast Carcinoma
Dana-Farber Cancer Institute 90
Not applicableEnded earlyNCT05289466
What this trial is testing

Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation.

Who this might be right for
IORT-Intra-Operative Radiation Therapy
Saint John's Cancer Institute 5
Not applicableStudy completedNCT00044980
What this trial is testing

Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate Cancer

Who this might be right for
MalnutritionProstate Cancer
Duke University
Testing effectiveness (Phase 2)WithdrawnNCT04373083
What this trial is testing

Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Regeneron Pharmaceuticals
Next Page